Clinical efficacy of ONC201 in H3K27M-mutant diffuse midline gliomas is driven by disruption of integrated metabolic and epigenetic pathways

Overview of attention for article published in Cancer Discovery, August 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#15 of 4,166)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 203 X posts from 121 X users, with an upper bound of 583,816 followers.

RT @InnovOncology: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and…

RT @InnovOncology: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and…

RT @chimerix: Excited to share today Dr. Koschmann’s publication in Cancer Discovery on ONC201 in H3K27M-DMG where frontline mOS demonstrat…

RT @InnovOncology: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 199 additional X posts.